Company

Enliven Therapeutics Inc ELVN

Tracked across 2 disclosed holders on Protégé.

2 tracked investors, latest 13F quarter ending 30 Jun 2026 · latest filing 14 Aug 2026

Held by these investors

All of 2 tracked investors by weight in their own portfolio. Source: each investor's latest SEC Form 13F-HR; quarter end and filing date per row.
InvestorWeight in portfolioValue (13F)Quarter endingFiled
Samlyn Capital0.8%$46.3M2026-06-302026-08-14
Baker Brothers Investments0.2%$45.9M2026-06-302026-08-14

Sources: SEC EDGAR (Form 13F-HR and Form 4) and the official House and Senate STOCK Act disclosures. Filings are quarterly or delayed, so current holdings may differ. Weights are each holder's own portfolio share, not a share of the company.

Open the companies explorer for ELVN